Treadlines acquires intellectual property from collaboration with Endo The Trendlines Group announced it has completed the acquisition of intellectual property developed within the framework of an R&D agreement with Endo International. The agreement, which was signed in 2012, called for the co-development of novel medical devices and technologies in the areas of men's health, women's health and homecare with Endo. Under the acquisition agreement, Trendlines takes commercial responsibility for all intellectual property created in accordance with the parties' agreement, while Endo benefits from revenues resulting from commercialization.
Endo rallies amid talk of conference cancellation Shares of Endo International are rallying 2% amid talk the company cancelled out of Leerink's conference next week. Endo has no events listed on its website and Bloomberg just reported that according to sources, the company cancelled its appearance at the conference. Shares of Endo are up $1.25 to $55.40 in afternoon trading.